Full title
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF)
Aim
The study investigates why some patients with heart failure show poor results in clinical study outcome, despite conventional treatments. Clinical laboratory and genetic data are compared to identify markers for patients with poor therapeutic response (death or hospitalization).
Study procedure
Multicentric, multinational, study-observation of biomarkers in therapeutic use of heart failure.
Patients involved in study
2.500 ( 525 patients through the SCIRENT network )
Study centers
50 centers in 12 European countries
Enrollment
12/2010 – 12/2012
Sponsor
Charité University Hospital (GER), University Hospital Groningen (NL), European Union (FP7)
Accepted duties
Implementation
Monitoring
Transportation of biomaterials
